Inventor · disambiguated record
Martyn Botfield
Also filed as: BOTFIELD MARTYN · BOTFIELD MARTYN C · BOTFIELD MARTYN CURTIS
22 granted patents·25 pending applications·1,379 citations·filing 2002–2022
97Inventor score
Top patents by PatentIndex Score
47 records- 0198US8999976B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2013·Granted Apr 7, 2015·105 cites·22 claims
- 0298US8969382B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2013·Granted Mar 3, 2015·66 cites·10 claims
- 0398US8796308B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2013·Granted Aug 5, 2014·73 cites·4 claims
- 0498US8785640B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2013·Granted Jul 22, 2014·72 cites·35 claims
- 0598US8765957B2Process for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2013·Granted Jul 1, 2014·73 cites·3 claims
- 0698US8604203B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2012·Granted Dec 10, 2013·73 cites·35 claims
- 0798US8598205B2Modulators of cystic fibrosis transmembrane conductance regulatorBINCH HAYLEY·Filed 2012·Granted Dec 3, 2013·77 cites·22 claims
- 0898US8513282B2Modulators of cystic fibrosis transmembrane conductance regulatorBINCH HAYLEY·Filed 2009·Granted Aug 20, 2013·84 cites·11 claims
- 0997US10646481B2Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2016·Granted May 12, 2020·21 cites·26 claims
- 1097US9751839B2Process for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2016·Granted Sep 5, 2017·41 cites·3 claims
- 1197US9371287B2Process for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2014·Granted Jun 21, 2016·55 cites·29 claims
- 1297US8835639B2Process for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2012·Granted Sep 16, 2014·72 cites·28 claims
- 1397US8614327B2Modulators of ATP-binding cassette transportersVERTEX PHARMA·Filed 2012·Granted Dec 24, 2013·78 cites·9 claims
- 1497US8436014B2Solid forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamideZHANG BEILI·Filed 2009·Granted May 7, 2013·87 cites·13 claims
- 1597US8367660B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2009·Granted Feb 5, 2013·85 cites·17 claims
- 1696US11564916B2Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2020·Granted Jan 31, 2023·7 cites·40 claims
- 1796US8633189B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2012·Granted Jan 21, 2014·68 cites·24 claims
- 1896US8614325B2Modulators of cystic fibrosis transmembrane conductance regulatorYANG XIAOQING·Filed 2011·Granted Dec 24, 2013·74 cites·12 claims
- 1996US8476442B2Process for making modulators of cystic fibrosis transmembrane conductance regulatorDEMATTEI JOHN·Filed 2010·Granted Jul 2, 2013·89 cites·13 claims
- 2094US8802700B2Modulators of ATP-Binding Cassette transportersSHETH URVI·Filed 2012·Granted Aug 12, 2014·74 cites·5 claims
- 2169US6949655B2Acyclic piperidine derivativesLAUFFER DAVID·Filed 2002·Granted Sep 27, 2005·5 cites·7 claims
- 2266US2010074949A1Pharmaceutical composition and administration thereofROWE WILLIAM·Filed 2009·Application pending·0 cites
- 2365US12458635B2Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2022·Granted Nov 4, 2025·0 cites·17 claims
- 2465US2014350281A1Process for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 2564US2017327456A1Process for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2017·Application pending·0 cites
- 2662US2014303204A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 2762US2014303205A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 2859US2014112988A1Pharmaceutical Composition and Administrations ThereofVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 2959US2012122921A1Process for making modulators of cystic fibrosis transmembrane conductance regulatorDEMATTEI JOHN·Filed 2011·Application pending·0 cites
- 3058US2013158071A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 3157US2014315948A1Pharmaceutical Composition and Administrations ThereofVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 3257US2013131107A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 3357US2005074824A1Quantification and site-specific profiling of protein phosphorylationFiled 2004·Application pending·0 cites
- 3454US2014343098A1Modulators of atp-binding cassette transportersVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 3554US2016221952A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 3652US2016022665A2Pharmaceutical Compositions and Administrations ThereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 3752US2012258983A1Pharmaceutical Composition and Administrations ThereofROWE WILLIAM·Filed 2012·Application pending·0 cites
- 3851US2016022664A2Pharmaceutical Compositions and Administrations ThereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 3951US2014113933A9Solid Forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamideVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 4051US2010028874A1Hepatitis c virus infection biomarkersRAMACHANDRAN RAVI K·Filed 2007·Application pending·0 cites
- 4147US2010256184A1Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2010·Application pending·0 cites
- 4245US2004180880A1Piperazine and piperidine derivativesFiled 2003·Application pending·0 cites
- 4344US2008318803A1Biomarkers for Monitoring Impdh Pathway InhibitionVERTEX PHARMACEUTICALS·Filed 2005·Application pending·0 cites
- 4439US2011257223A1Modulators of Cystic Fibrosis Transmembrane Conductance RegulatorVERTEX PHARMA·Filed 2011·Application pending·0 cites
- 4539US2012220625A1Pharmaceutical composition and administrations thereofROWE WILLIAM·Filed 2012·Application pending·0 cites
- 4635US2003191110A1Modulators of the cholesterol biosynthetic pathwayFiled 2002·Application pending·0 cites
- 4733US2005046421A1Methods for identifying a compound that can bind to membrane-bound receptorsFiled 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Martyn Botfield files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →